Hengrui medicine: ω- 3. Fatty acid ethyl ester 90 soft capsule has obtained the drug registration certificate
Hengrui pharmaceutical announcement, subsidiary ω- 3. Fatty acid ethyl ester 90 soft capsule has obtained the drug registration certificate. The drug can reduce the synthesis of triglycerides in the liver.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Apr 25, 2022 06:25 PM
· Healthcare
Yingkang life: it is expected to lose 300 million yuan to 370 million yuan in 2021
Briefing Apr 25, 2022 09:45 AM
The coal sector fell sharply at the opening, and Shanghai Energy fell by the limit
Consumer Staples · Analysis
The First Move of the U.S. Postal Service on Cross-Border E-commerce After Trump
"For many high-margin products, even with a 100% tariff, the cost of manufacturing in China is still far lower than local production. Therefore, from a business perspective, high-margin products will become a more prominent focus in cross-border trade. Companies should adjust their strategies to adapt to the new market environment." — Founder of a cross-border brand, interviewed by EqualOcean.
Yesterday 08:19 PM
Healthcare
Beijing Pilots The DRG External Payment Mode
DRG refers to the diagnosis-related group used to classify the patient and set up a system to ensure the care provided is necessary. The National Healthcare Security Administration will pay the hospital a predetermined amount according to a patient’s DRG.
Jul 16, 2022 12:12 AM
Briefing Mar 14, 2022 07:48 AM
· Healthcare
Defining key tasks and accelerating the construction of new urbanization
Healthcare · Analysis
New Normal, New Policies: A Focus on Healthcare in Two Sessions
The week-long Chinese virtual ‘Two Sessions’ meeting closed on May 28. The hovering pandemic has made the healthcare topic a highlight for the 2020 third session of the 13th National People’s Congress.
Jun 03, 2020 03:06 PM
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
The First Move of the U.S. Postal Service on Cross-Border E-commerce After Trump
Yesterday 08:19 PM
Insight
In-depth
Insight
In-depth
Insight
In-depth
Automotive · Analysis
Shanghai and Shenzhen: The Dual-City Landscape and Corporate Power
Jan 09, 2025 03:35 PM